Striatal graft projections are influenced by donor cell type and not the immunogenic background

Brain

Volumn 130, Issue 5, 2007, Pages 1317-1329

  Kelly, Claire M ^a   Precious, Sophie V ^a   Penketh, Richard ^b   Amso, Nazar ^b   Dunnett, Stephen B ^a   Rosser, Anne E ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Allograft; Precursor cells; Transplantation; Xenograft

Indexed keywords

BETA GALACTOSIDASE; BIOTIN; CHLORTETRACYCLINE; CYCLOSPORIN A; GREEN FLUORESCENT PROTEIN; TRACER;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL ELONGATION; CELL LABELING; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DONOR; EMBRYO; FETUS; FETUS (ANATOMY); FETUS CELL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOGENICITY; INFECTION PREVENTION; IONTOPHORESIS; MOUSE; NERVE CELL GROWTH; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE; XENOGRAFT; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; FEMALE; FETAL TISSUE TRANSPLANTATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOHISTOCHEMISTRY; LACTOSE OPERON; NERVE CELL; NERVE FIBER; NERVE TRACT; PATHOLOGY; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; AXONS; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; LAC OPERON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL PATHWAYS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34249680738     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm053     Document Type: Article

References (26)

1. Armstrong RJE, Huelbrink CB, Tyres P, Ratcliffe EL, Richards A, Dunnett SB, et al. The potentail for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. Exp Neurol 2002; 175: 98-111.
2. Armstrong RJE, Tyers P, Jain M, Richards A, Dunnett SB, Rosser AE, et al. Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease. Exp Brain Res 2003; 151: 204-17.
3. Armstrong RJE, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuroanl differentiation and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's Disease. Cell Transplant 2000; 9: 1-10.
4. Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006; 5: 303-9.
5. Department of Health. Guidance on the supply of fetal tissue for research diagnosis and therapy. London, 1995.
6. Dunnett SB, Bjorklund A. Neural transplantation a practical approach; Oxford University Press, 1992.
7. Eriksson C, Bjorklund A, Wictorin K. Neuronal differentiation following transplantation of expanded mouse neurosphere cultures derived from different embryonic forebrain regions. Exp Neurol 2003; 184: 615-35.
8. Evtouchenko L, Studer L, Spenger C, Dreher E, Seiler RW. A mathematical model for the estimation of human embryonic and fetal age. Cell Transplant 1996; 5: 453-64.
9. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 1996; 93: 10887-90.
10. Fricker RA, Barker RA, Fawcett JW, Dunnett SB. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant 1996; 4: 173-200.
11. Fricker-Gates RA, Lundberg C, Dunnett SB. Neural transplantation: restoring complex circuitry in the striatum. Restor Neurol Neurosci 2001; 19: 119-38.
12. Garcia AR, Deacon TW, Dinsmore J, Isacson O. Extensive axonal and glial fiber growth from fetal porcine cortical xenografts in the adult rat cortex. Cell Transplant 1995; 4: 515-27.
13. Hurelbrink CB, Tyers P, Armstrong RJ, Dunnett SB, Barker RA, Rosser AE. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease. Cell Transplant 2003; 12: 687-95.
14. Isacson O, Brundin P, Kelly PA, Gage FH, Bjorklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 1984; 311: 458-60.
15. Kelly CM, Dunnett SB, Rosser AE. Cell-based therapy for Huntington's disease. In: Sanberg PR CDDa, editor. Cell therapy for brain repair. Vol. 1. Totowa: Humana Press Inc.; 2006. p. 83-117.
16. Kelly CM, Tyers P, ter Borg MG, Svendsen CN, Dunnett SB, Rosser AE. Mouse and rat embryonic neural precursor responsivness to EGF and FGF-2 and the effects of rat gestation. Brain Res Bull 2005; 68: 83-94.
17. Novikov LN. Labeling of central projections of primary afferents in adult rats: a comparison between biotinylated dextran amine, neurobiotin and Phaseolus vulgaris-leucoagglutinin. J Neurosci Methods 2001; 112: 145-54.
18. Polkinghorne J. Review of the guidance on the research use of fetuses and fetal material. London: HMSO; 1989.
19. Pritzel M, Isacson O, Brundin P, Wiklund L, Bjorklund A. Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. Exp Brain Res 1986; 65: 112-26.
20. Pundt LL, Kondoh T, Conrad JA, Low WC. Transplantation of human striatal tissue into a rodent model of Huntington's disease: phenotypic expression of transplanted neurons and host-to-graft innervation. Brain Res Bull 1996; 39: 23-32.
21. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med 1997; 3: 421-8.
22. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 1999; 22: 51-61.
23. Wictorin K. Anatomy and connectivity of intrastriatal striatal transplants. Prog Neurobiol 1992; 38: 611-39.
24. Wictorin K, Brundin P, Sauer H, Lindvall O, Bjorklund A. Longdistance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult-rats. J Comp Neurol 1992; 323: 475-94.
25. Wictorin K, Clarke DJ, Bolam JP, Brundin P, Gustavii B, Lindvall O, et al. Extensive efferent projections of intra-striatally transplanted striatal neurons as revealed by a species-specific neurofilament marker and anterograde axonal tracing. Prog Brain Res 1990; 82: 391-9.
26. Wictorin K, Simerly RB, Isacson O, Swanson LW, Bjorklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-III. Efferent projecting graft neurons and their relation to host afferents within the grafts. Neuroscience 1989; 30: 313-30.